Clinical Trials Browser

Phase 2 × recombinant interferon alpha 2b-like protein × Clear all

NCT02068131 2016-01-05

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT02455596 2016-01-05

Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

Phase 2 Unknown

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors